Global advisory and business development firm specializing in biosimilar and biologic licensing in/out, pipeline strategy, regulatory navigation, and market entry across North America, Europe, and Latin America. • Generated USD 12 million in annual revenue through licensing deal closures and strategic partnership agreements. • Served as strategic advisor to multinational pharma and biotech companies on biosimilar pipeline development, licensing in/out strategy, deal structuring, and partner identification — providing senior executive-level guidance across market entry and portfolio expansion decisions. Notable engagements include an 11-year partnership with Cassara Laboratories as an embedded biosimilar Business Development advisor at different markets. • Secured RAMQ approval (Régie de l'assurance maladie du Québec) for pharmaceutical products — navigating complex Canadian regulatory pathways for market access. • Built and maintained a network of pharma and biotech executives across 5 continents — accelerating BD cycles and opening previously untapped markets. • Conducted pipeline portfolio analysis and identified business opportunities across global markets — from early- stage biosimilar candidates to late-stage commercialization assets. • Led end-to-end licensing partner identification and deal structuring — including regulatory pathway analysis, partner evaluation, and term sheet negotiation for market entry in Latin America and Europe. • Served clients across the pharma and biotech spectrum — from emerging biosimilar startups to established multinational companies — across North America, Europe, and Latin America.

across North American markets. • Established commercial agreements with pharmaceutical companies for biosimilar, generic, and Rx products. • Sales Growth: Grew revenue from $1.9M (2008) to $9.1M (2011)—a379% increase over three years — through licensing and business development activities. • Conducted market research and pipeline analysis to identify new launch opportunities across North America.

— Colombia & Peru and biotechnology sector across Latin America. • Led the development of logistics and commercial solutions for biosimilar, biotechnology, and pharmaceutical products entering new markets. • Managed a team of 20 staff across Colombia and Peru — overseeing commercial operations and strategic partnerships. • Established strategic alliances with CROs and international partners to expand distribution channels globally. • Provided operational support to international clinical studies and CROs across Colombia and Peru, facilitating regulatory compliance and site coordination.

— Central America & Caribbean pharmaceutical company operating across Central America and the Caribbean. • Identified and developed pharmaceutical market opportunities across eight countries: Guatemala, Belize, Honduras, El Salvador, the Dominican Republic, Cuba, Mexico, and Panama. • Sales Growth: Achieved USD 950K in incremental sales growth in 2004 compared to 2003. • Led licensing activities, partner identification, and business development capacity-building across regional subsidiaries. • Managed a team of 70 employees.

• Appointed as global commercial lead for Enbrel (Etanercept) focused primary to immunology market, launch across Asia-Pacific, Europe, and Latin America — one of the world's pioneering biologic assets and precursor to today's biosimilar landscape. Coordinated across 15+ countries including Japan, Australia, India, Germany, Argentina, and Brazil. • Enbrel (Etanercept): Record global sales of USD 650M (2000). Argentina: USD 3.6M with 260% unit growth. • BeneFIX (Hemophilia B) & ReFacto (Hemophilia A): Record global sales of USD 190M with a $20M operating budget (2000) for those recombinant products. • Managed a global cross-functional team of 15 — coordinating with medical, regulatory, and manufacturing departments worldwide. • Led KOL selection by country and organized the Global Advisory Board for Rheumatology and Immunology markets across Asia-Pacific, Europe, and Latin America.

digital solutions, and healthcare content for the Argentine pharma market. • E-Business Product Development: Collaborated with medical associations to develop e-business solutions designed to streamline the submission, evaluation, and management of medical studies for presentation at international conferences. • Healthcare Communications: Produced specialized newsletters for healthcare professionals across multiple therapeutic areas and developed medical education programs for the pharmaceutical industry. • Gained early exposure to digital health innovation and pharmaceutical marketing — experience that later informed multichannel launch strategies across global markets.